Dr. Richard Hratchia Havunjian, MD

Dr. Havunjian practices at Major Medical Management, Inc. in Glendale, California.

Dr. Havunjian's NPI, 1851475594, was assigned on October 25, 2006. Dr. Havunjian graduated from University of North Carolina School of Medicine in 1987. Dr. Havunjian holds California license G63659.

Dr. Havunjian's primary practice is Major Medical Management, Inc., at 1510 S Central Ave, Glendale, CA 91204 in Los Angeles County. The practice phone is (818) 242-3668.

Dr. Havunjian's primary practice is Major Medical Management, Inc. in Glendale, California. Dmand AI also links Dr. Havunjian to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Havunjian practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Havunjian's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Havunjian is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Havunjian is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Havunjian treats.

CMS data shows 7,965 Medicare services from Dr. Havunjian across 34 procedure codes in 2024, for 1,337 Medicare patients. Medicare paid $878,101 for them.

CMS counts 1,337 Medicare patients who saw Dr. Havunjian in 2024. The largest group is 65 to 74, with 629 patients. 75% of them have arthritis, and 75% have high blood pressure. 88% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Havunjian's median patient age at 69, with 63% women.

In 2024, Dr. Havunjian wrote 5,790 Medicare Part D claims for 891 patients. 42% of them were for generic drugs. CMS names the drug for 5,702 of them, across 43 drugs with 11 or more claims each, at $1,328,589 in total drug cost. In 2023, CMS named 6,177 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Havunjian for performance year 2024, reported as part of a group. Dr. Havunjian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 283 procedures of cataract surgery by Dr. Havunjian, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Havunjian. The most frequent topics are Cell Membrane, Ligands and Rats, Inbred Strains.

CMS Open Payments shows 62 general payments to Dr. Havunjian from 14 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $996.

Dmand AI lists 1 award for Dr. Havunjian.

Dr. Havunjian graduated from University of North Carolina School of Medicine in 1987. Dr. Havunjian is a member of AAO and ASCRS.

Dr. Havunjian is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.